| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.44 | 4e-45 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.38 | 3e-28 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.37 | 3e-28 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.39 | 5e-18 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-12 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.29 | 9e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-08 |